Marvell & IP Infusion Target SDN
SANTA CLARA, Calif. and LAS VEGAS -- Marvell (Nasdaq: MRVL) today announced the general availability of new devices within the Prestera® CX family of packet processors. The new processors feature support for high-density 40GbE/10GbE ports for cloud storage and server interconnect solutions, as well as Ethernet backplanes in modular platforms. The Prestera CX device family has been purpose built for highly demanding system architectures, spanning 160G to 1.28T in packet processing capabilities. It offers a line of footprint compatible devices enabling a comprehensive portfolio of products leveraging maximal efficiencies in development efforts. A flexible port mapping scheme allows a variety of physical interconnects, fostering a range of solutions with proprietary ASICs, third-party FPGA, as well as Marvell's Alaska® PHY devices. In addition to announcing the availability of the Prestera CX, Marvell also introduced its continued collaboration with IP Infusion. The integrated Marvell Prestera CX8129 and IP Infusion ZebIC solution will enable the next generation of software defined networks, accelerating the seamless delivery of cloud-based services. Supporting capabilities for next-generation IP RAN, base stations and packet transport solutions, the Prestera CX8129 enables timing and synchronization support for applications enabling a new set of services for monetization within the public cloud and carrier and telecommunications infrastructure. Marvell Technology Group Ltd.